Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus

被引:0
|
作者
Steven Vernino
Daniel Claassen
机构
[1] UT Southwestern,Department of Neurology and Neurotherapeutics
[2] University of Southern California,Department of Neurology
来源
Clinical Autonomic Research | 2017年 / 27卷
关键词
Type 2 diabetes mellitus; Parkinson disease; Neurogenic orthostatic hypotension; Droxidopa;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:33 / 34
页数:1
相关论文
共 44 条
  • [21] Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer
    Cutsforth-Gregory, Jeremy K.
    Low, Phillip A.
    NEUROLOGY AND THERAPY, 2019, 8 (02) : 307 - 324
  • [22] Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease
    Peter A. McCullough
    Cardiology and Therapy, 2019, 8 : 145 - 150
  • [23] Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management
    Grosu, Cristina
    Noea, Otilia
    Mastaleru, Alexandra
    Ignat, Emilian Bogdan
    Leon, Maria Magdalena
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [24] Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy
    Goodman, Brent P.
    Gupta, Fiona
    CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S21 - S23
  • [25] Neurogenic orthostatic hypotension as the initial feature of Parkinson disease
    Milazzo, Valeria
    Di Stefano, Cristina
    Servo, Serena
    Zibetti, Maurizio
    Lopiano, Leonardo
    Maule, Simona
    CLINICAL AUTONOMIC RESEARCH, 2012, 22 (04) : 203 - 206
  • [26] Neurogenic orthostatic hypotension as the initial feature of Parkinson disease
    Valeria Milazzo
    Cristina Di Stefano
    Serena Servo
    Maurizio Zibetti
    Leonardo Lopiano
    Simona Maule
    Clinical Autonomic Research, 2012, 22 : 203 - 206
  • [27] Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy
    Brent P. Goodman
    Fiona Gupta
    Clinical Autonomic Research, 2017, 27 : 21 - 23
  • [28] Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension
    Steven Vernino
    Mark Lew
    Daniel Kremens
    Clinical Autonomic Research, 2017, 27 : 35 - 37
  • [29] Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension
    Vernino, Steven
    Lew, Mark
    Kremens, Daniel
    CLINICAL AUTONOMIC RESEARCH, 2017, 27 : 35 - 37
  • [30] Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)
    Hauser, Robert A.
    Isaacson, Stuart
    Lisk, Jerome P.
    Hewitt, L. Arthur
    Rowse, Gerry
    MOVEMENT DISORDERS, 2015, 30 (05) : 646 - 654